Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition On February 5, 2026, Arrowhead Pharmaceuticals, Inc. announced and commented on its fiscal 2026 financial results
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated February 5, 2026. 104 Cover Page Interactive Data File (the